PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Compass Pathways published the long awaited results of its phase 2 clinical trial for the treatment of depression with psilocybin–assisted psychotherapy in the New England Journal of Medicine.
Psilocybin showed rapid antidepressant effects for most patients, but only 1 in 5 participants showed significant improvement at 12 weeks.
Read moreThe harms of psychedelics need to be put Into context.
As psychedelic therapy trials get bigger and the drugs become more accessible, researchers need to start talking about their potential adverse effects.
Read morePsychedelic drugs can induce mind-altering states affecting perception, thought and sensory input.
They have historically been known for their recreational use and do not have nationwide legal approval.
However, psychedelic drugs are also increasingly being studied for their medical benefits (particularly with regard to mental health).
Learn more below about how certain psychedelics can—and cannot—be used for mental wellness.
Read moreWhat do athletes get from ayahuasca, mushrooms and ecstasy?
Aaron Rodgers and Kenny Stills are among the few who have spoken publicly about their use of psychedelics for mental health purposes.
But a future where the treatment is more widespread across sports may not be so far away.
Read moreHere’s an article summarizing the types of therapy used with psychedelics for integration.
I use them all!
Read morePsychedelic medicine has a duty to respect its indigenous roots.
Here’s how we can pay indigenous people the respect they deserve.
Read moreIn a peer-reviewed essay published in the journal Anthropology of Consciousness, Devenot and her co-authors look forward to a culture that makes these medicines available in a safe and affordable way that respects the traditions behind them.
I could not agree more!
Read moreCould psychedelics make you more creative? Shift your mind, connect you to others, and help you access a younger, more malleable version of yourself? Activist Rick Doblin, neuroscientist Gül Dölen, and musician Reggie Watts join Brian Greene for a mind-bending and multidisciplinary conversation about the promises and pitfalls of these "magic" molecules and their impact on creativity, connection, and consciousness.
This program is part of the Big Ideas series, supported by the John Templeton Foundation.
Read moreHere’s an interesting look at the history of psychedelics and some trends.
Read moreAccording to a new survey conducted by researchers at Johns Hopkins Medicine, published Aug. 24 in the journal PLOS ONE, people’s attitudes about death change after both a psychedelic drug experience and a non-drug-related out-of-body experience.
People were less afraid of death than they had been before their experiences.
Read more